APTO has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
APTO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Other Income (Minority Interest) represents par value or stated value of the subsidiary stock not owned by the parent company plus the minority interest's equity in the surplus of the subsidiary. Aptose Biosciences's Other Income (Minority Interest) for the three months ended in Sep. 2024 was $0.00 Mil. Its Other Income (Minority Interest) for the trailing twelve months (TTM) ended in Sep. 2024 was $0.00 Mil.
The historical data trend for Aptose Biosciences's Other Income (Minority Interest) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aptose Biosciences Annual Data | |||||||||||||||||||||
Trend | May14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Other Income (Minority Interest) | Get a 7-Day Free Trial | - | - | - | - | - |
Aptose Biosciences Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Other Income (Minority Interest) | Get a 7-Day Free Trial | - | - | - | - | - |
Other Income (Minority Interest) represents par value or stated value of the subsidiary stock not owned by the parent company plus the minority interest's equity in the surplus of the subsidiary.
Other Income (Minority Interest) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aptose Biosciences (NAS:APTO) Other Income (Minority Interest) Explanation
Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company. It is reported on the consolidated income statement as a share of profit belonging to minority shareholders.
William G. Rice | director, officer: Chair, President & CEO | C/O APTOSE BIOSCIENCES INC., 251 CONSUMERS ROAD, SUITE 1105, TORONTO A6 M2J 4R3 |
Bernd R. Seizinger | director | 535 BOYLSTON STREET, BOSTON MA 02116 |
Fletcher Payne | officer: SR VP & Chief Fin. Officer | 260 LITTLEFIELD AVENUE, SOUTH SAN FRANCISCO CA 94080 |
Philippe Ledru | officer: Chief Commercial Officer | C/O APTOSE BIOSCIENCES INC., 2511 CONSUMERS ROAD, SUITE 1105, TORONTO A6 M2J 4R3 |
Denis R Burger | director | CYTODYN INC., 1111 MAIN STREET, SUITE 660, VANCOUVER WA 98660 |
Erich Platzer | director | |
Rafael Bejar | officer: Chief Medical Officer | C/O APTOSE BIOSCIENCES INC., 251 CONSUMERS ROAD, SUITE 1105, TORONTO A6 M2J 4R3 |
Wilson Donald R. Jr. | 10 percent owner | 540 W. MADISON ST., SUITE 2500, CHICAGO IL 60661 |
Drw Holdings, Llc | 10 percent owner | 540 W. MADISON ST., SUITE 2500, CHICAGO IL 60661 |
Drw Commodities, Llc | 10 percent owner | 540 W. MADISON ST., SUITE 2500, CHICAGO IL 60661 |
Warren Whitehead | director | C/O APTOSE BIOSCIENCES INC., 251 CONSUMERS ROAD, SUITE 1105, TORONTO A6 M2J 4R3 |
Gregory K. Chow | officer: Senior VP & CFO | C/O APTOSE BIOSCIENCES INC., 251 CONSUMERS ROAD, SUITE 1105, TORONTO A6 M2J 4R3 |
Jotin Marango | officer: Senior VP, Chief Bus. Officer | C/O APTOSE BIOSCIENCES INC., 251 CONSUMERS ROAD, SUITE 1105, TORONTO A6 M2J 4R3 |
Caroline M Loewy | director | 300 ELLIOTT AVE WEST, SUITE 500, SEATTLE WA 98119-4114 |
Mark D. Vincent | director | C/O APTOSE BIOSCIENCES INC., 251 CONSUMERS ROAD, SUITE 1105, TORONTO A6 M2J 4R3 |
From GuruFocus
By Marketwired • 06-14-2024
By Marketwired • 11-20-2024
By Marketwired • 09-05-2024
By Marketwired • 12-03-2024
By Marketwired • 06-18-2024
By GuruFocus Research • 02-06-2024
By Marketwired • 08-30-2024
By Marketwired • 11-08-2024
By GuruFocus Research • 02-06-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.